We also got the same trend in CGGA mRNA sequence database 2 and the OS distinguishing effects of SAMD9 expression level were very significant in all glioma and LGG (Supplementary Figure 2Ap < 0.0001; Supplementary Figure 2Bp = 0.0002). The gene discussed is SAMD9; the disease is central nervous system cancer.